KOL kliniske forsøg i Ohio
17 studier for KOL søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Blue Ash
- Research Site, Columbus
- Research Site, Marion
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 2. okt. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Asthma & Allergy Center - Toledo- Site Number : 8400110, Toledo
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 1. okt. 2026 · NCT07190222WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
- Ohio State East Hospital, Columbus
- OSU Wexner Medical Center, Columbus
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07558265To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Remington-Davis Research, Columbus
RekruttererFase 2
Alder 40 til 85 · Alle køn · Opdateret 30. sep. 2026 · NCT07684820A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50003, Columbus
RekruttererFase 2
Alder 40 til 80 · Alle køn · Opdateret 25. sep. 2026 · NCT07725939Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Dayton Clinical Research- Site Number : 8400124, Dayton
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07190209A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Cleveland
- Research Site, Marion
RekruttererFase 2
Alder 40 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Columbus
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Toledo Institute of Clinical Research Inc., Toledo
RekruttererFase 2/3
Alder 35 til 80 · Alle køn · Opdateret 31. aug. 2026 · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 104, Cleveland
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 11. aug. 2026 · NCT07555483Multi-Center Clean Air Randomized Controlled Trial in COPD
- Cleveland Clinic, Cleveland
RekruttererFase 3
Alder 40 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT06376994PEP Buddy in Pulmonary Rehabilitation
- Cincinnati VA Medical Center, Cincinnati, OH, Cincinnati
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Rekrutterer
Alder 40 til 89 · Alle køn · Opdateret 24. jul. 2026 · NCT07404826Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Ohio State University Medical Center - Ohio State Lung Center, Columbus
Rekrutterer
Alder 40 til 80 · Alle køn · Opdateret 28. apr. 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Cleveland Clinic Foundation, Cleveland
- The Ohio State University, Columbus
Rekrutterer
Alder 40 til 84 · Alle køn · Opdateret 24. apr. 2026 · NCT06891755Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
- Cleveland Clinic Foundation, Cleveland
Rekrutterer
Alder 40 og opefter · Alle køn · Opdateret 30. okt. 2025 · NCT07059637myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Cincinnati VA Medical Center, Cincinnati
- Cleveland Clinic Foundation, Cleveland
- Ohio State University Wexner Medical Center, Columbus
Rekrutterer
Alder 30 og opefter · Alle køn · Opdateret 6. feb. 2025 · NCT05204888PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
- MetroHealth, Cleveland
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 12. okt. 2023 · NCT05306743Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.